Cargando…
Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
Purpose: There is uncertainty regarding the appropriate dose of Cannabidiol (CBD) for childhood epilepsy. We present the preliminary data of seven participants from the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) study. Methods: The study is an open-label, prospective,...
Autores principales: | Huntsman, Richard J., Tang-Wai, Richard, Alcorn, Jane, Vuong, Stephanie, Acton, Bryan, Corley, Scott, Laprairie, Robert, Lyon, Andrew W., Meier, Simona, Mousseau, Darrell D., Newmeyer, Doris, Prosser-Loose, Erin, Seifert, Blair, Tellez-Zenteno, Jose, Huh, Linda, Leung, Edward, Major, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616248/ https://www.ncbi.nlm.nih.gov/pubmed/31333569 http://dx.doi.org/10.3389/fneur.2019.00716 |
Ejemplares similares
-
The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study
por: Reithmeier, Darren, et al.
Publicado: (2018) -
Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022) -
Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing
por: Gong, Xiaoxiang, et al.
Publicado: (2022) -
Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy
por: Kuchenbuch, Mathieu, et al.
Publicado: (2020) -
Functional Connectivity Derived From Electroencephalogram in Pharmacoresistant Epileptic Encephalopathy Using Cannabidiol as Adjunctive Antiepileptic Therapy
por: Morales Chacón, Lilia Maria, et al.
Publicado: (2021)